This issue brief details the Alliance of Hippocratic Medicine challenge to the FDA's approval of the abortion pill, mifepristone. It provides context for the challenge, as well as what some of the possible rulings in the case could mean for access to medication abortion.
[This is part four of a series on the first-of-its-kind federal lawsuit, Americans for Hippocratic Medicine v. U.S. Food and Drug Administration, in which doctors and medical practitioners are asking the courts to hold the FDA accountable for its reckless and illegal approval of dangerous chemical abortion drugs.]